Risorse esterne
Opinione della community
Prezzo Variazione Volume
3.1 0 €
P/E Obiettivo ad 1anno
0 7.8 €

Compra - Vendi

Tutte le tue transazioni per questo titolo

Devi effettuare l'accesso


Altri utenti che hanno investito

Transations in last week
Buy: 4
Sell : 2

Genny cash AngerManagement



Fate Therapeutics, Inc. (NasdaqGM:FATE): A Look at What's Behind the Numbers & Volatility - Clayton News

Watching some historical volatility numbers on shares of Fate Therapeutics, Inc. (NasdaqGM:FATE), we can see that the 12 month volatility is presently 81.039100. The 6 month ... There are many different views when it comes to trading stocks. Investors ...altro » Leggi

Fate Therapeutics (FATE) EPS Estimated At $-0.25, ADVENT/CLAYMORE Enhanced Growth (LCM) SI Increased By ... - San Times

About 83,334 shares traded. Advent Claymore Enhanced Growth & Income (NYSE:LCM) has risen 7.81% since July 20, 2016 and is uptrending. It has underperformed by 8.89% the S&P500. Analysts expect Fate Therapeutics Inc (NASDAQ:FATE) to report ...altro » Leggi

Investors Set Sail on Valuation For Fate Therapeutics, Inc. (NasdaqGM:FATE) - Stock Talker

The ERP5 of Fate Therapeutics, Inc. (NasdaqGM:FATE) is 14751. The lower the ERP5 rank, the more undervalued a company is thought to be. The MF Rank (aka the Magic Formula) is a formula that pinpoints a valuable company trading at a good price.altro » Leggi

Fate Therapeutics (NASDAQ:FATE) Getting Somewhat Positive ... - The Cerbat Gem

Press coverage about Fate Therapeutics (NASDAQ:FATE) has been trending somewhat positive this week, Accern Sentiment Analysis reports. Accern identifies ... Leggi

EPS for Adamas Pharmaceuticals (ADMS) Expected At $-0.85, Fate Therapeutics (FATE) Sellers Decreased By 2.94 ... - Bibeypost.com

With 172,500 avg volume, 4 days are for Fate Therapeutics Incorporated (NASDAQ:FATE)'s short sellers to cover FATE's short positions. The SI to Fate Therapeutics Incorporated's float is 2.51%. The stock increased 1.64% or $0.05 during the last trading ... Leggi

Fate Therapeutics Inc (FATE) Closes Last Session Above PSAR - Lenox Ledger

Active traders have a wide range of technical indicators at their disposal for when completing technical stock analysis. Currently, the 14-day ATR for Fate Therapeutics Inc (FATE) is spotted at 0.20. First developed by J. Welles Wilder, the ATR may ... Leggi

Fate Therapeutics Inc (FATE)'s Chaikin Flow Showing Positive ... - FLBC News

Fate Therapeutics Inc (FATE) is seeing positive money flow as the Chalkin (CMF) indicator is holding above the zero line. The Chaikin Money Flow Indicator is ...altro » Leggi

Fate Therapeutics, Inc. (FATE) skyrockets 103.23% since hitting worst price of $1.55 - Post Analyst

Multiple company employees have indulged in significant insider trading. Fate Therapeutics, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that Chief Medical Officer Storgard Chris has acquired 37,593 shares of ... Leggi

Remarkable stock of Recent Trading -: Fate Therapeutics, Inc. (FATE ... - Hot Stocks Point

USA based company, Fate Therapeutics, Inc. (FATE)'s latest closing price distance was at -4.77% from the average-price of 200 days while it maintained a ... Leggi

Popular Mover to Observe-: Fate Therapeutics, Inc. (FATE) - Hot Stocks Point

Fate Therapeutics, Inc. (FATE) ended its day with loss -1.90% and finalized at the price of $3.09. During its last trading session, Stock traded with the total exchanged volume of 0.19 million shares. The average volume stands around 0.27 million shares. Leggi